Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884 · see citing works

Clinical characteristics of coronavirus disease 2019 in China

Guan, W.-J., Ni, Z.-Y., Hu, Y., Liang, W.-H., Ou, C.-Q., He, J.-X., Liu, L., Shan, H., Lei, C.-L., Hui, D. S. C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2002032 · Cited by 30,246 · see citing works

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

Zhou, F., Yu, T., Du, R., Fan, G., Liu, Y., Liu, Z., Xiang, J., Wang, Y., Song, B., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30566-3 · Cited by 27,263 · see citing works

Epidemiological and clinical characteristics of 99 cases of 2019 novel Coronavirus pneumonia in Wuhan, China: a descriptive study.

Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., Qiu, Y., Wang, J., Liu, Y., Wei, Y., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30211-7 · Cited by 21,415 · see citing works

COVID-19: consider cytokine storm syndromes and immunosuppression

Mehta, P., McAuley, D. F., Brown, M., Sanchez, E., Tattersall, R. S., & Manson, J. J. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30628-0 · Cited by 9,664 · see citing works

Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area

Richardson, S., Hirsch, J. S., Narasimhan, M., Crawford, J. M., McGinn, T., Davidson, K. W., and the Northwell COVID-19 Research Consortium, Barnaby, D. P., Becker, L. B., Chelico, J. D., et al. (2020) · JAMA · doi:10.1001/jama.2020.6775 · Cited by 9,254 · see citing works

Pathological findings of COVID-19 associated with acute respiratory distress syndrome

Xu, Z., Shi, L., Wang, Y., Zhang, J., Huang, L., Zhang, C., Liu, S., Zhao, P., Liu, H., Zhu, L., et al. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30076-x · Cited by 8,545 · see citing works

Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China

Wu, C., Chen, X., Cai, Y., Xia, J., Zhou, X., Xu, S., Huang, H., Zhang, L., Zhou, X., Du, C., et al. (2020) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2020.0994 · Cited by 8,249 · see citing works

Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis

Hamming, I., Timens, W., Bulthuis, M., Lely, A., Navis, G., & van Goor, H. (2004) · The Journal of Pathology · doi:10.1002/path.1570 · Cited by 5,676 · see citing works

Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China

Ruan, Q., Yang, K., Wang, W., Jiang, L., & Song, J. (2020) · Intensive Care Medicine · doi:10.1007/s00134-020-05991-x · Cited by 4,898 · see citing works

Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China

Qin, C., Zhou, L., Hu, Z., Zhang, S., Yang, S., Tao, Y., Xie, C., Ma, K., Shang, K., Wang, W., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa248 · Cited by 4,775 · see citing works

Clinical and immunological features of severe and moderate coronavirus disease 2019

Chen, G., Wu, D., Guo, W., Cao, Y., Huang, D., Wang, H., Wang, T., Zhang, X., Chen, H., Yu, H., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci137244 · Cited by 4,750 · see citing works

Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19

Blanco-Melo, D., Nilsson-Payant, B. E., Liu, W.-C., Uhl, S., Hoagland, D., Møller, R., Jordan, T. X., Oishi, K., Panis, M., Sachs, D., et al. (2020) · Cell · doi:10.1016/j.cell.2020.04.026 · Cited by 4,222 · see citing works

Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy

Tang, N., Bai, H., Chen, X., Gong, J., Li, D., & Sun, Z. (2020) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.14817 · Cited by 3,554 · see citing works

A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus–induced lung injury

Kuba, K., Imai, Y., Rao, S., Gao, H., Guo, F., Guan, B., Huan, Y., Yang, P., Zhang, Y., Deng, W., et al. (2005) · Nature Medicine · doi:10.1038/nm1267 · Cited by 3,445 · see citing works

Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients

Hadjadj, J., Yatim, N., Barnabei, L., Corneau, A., Boussier, J., Smith, N., Péré, H., Charbit, B., Bondet, V., Chenevier-Gobeaux, C., et al. (2020) · Science · doi:10.1126/science.abc6027 · Cited by 2,984 · see citing works

Trained immunity: A program of innate immune memory in health and– disease

Netea, M. G., Joosten, L. A. B., Latz, E., Mills, K. H. G., Natoli, G., Stunnenberg, H. G., O’Neill, L. A. J., & Xavier, R. J. (2016) · Science · doi:10.1126/science.aaf1098 · Cited by 2,768 · see citing works

Effective treatment of severe COVID-19 patients with tocilizumab

Xu, X., Han, M., Li, T., Sun, W., Wang, D., Fu, B., Zhou, Y., Zheng, X., Yang, Y., Li, X., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2005615117 · Cited by 2,636 · see citing works

Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19

Liao, M., Liu, Y., Yuan, J., Wen, Y., Xu, G., Zhao, J., Cheng, L., Li, J., Wang, X., Wang, F., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0901-9 · Cited by 2,614 · see citing works

Pathogenic human coronavirus infections: Causes and consequences of cytokine storm and immunopathology

Channappanavar, R., & Perlman, S. (2017) · Seminars in Immunopathology · doi:10.1007/s00281-017-0629-x · Cited by 2,524 · see citing works

Reduction and Functional Exhaustion of T Cells in Patients With Coronavirus Disease 2019 (COVID-19)

Diao, B., Wang, C., Tan, Y., Chen, X., Liu, Y., Ning, L., Chen, L., Li, M., Liu, Y., Wang, G., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00827 · Cited by 2,475 · see citing works

SARS-CoV-2 Receptor ACE2 Is an Interferon-Stimulated Gene in Human Airway Epithelial Cells and Is Detected in Specific Cell Subsets across Tissues

Ziegler, C. G. K., Allon, S. J., Nyquist, S. K., Mbano, I. M., Miao, V. N., Tzouanas, C. N., Cao, Y., Yousif, A. S., Bals, J., Hauser, B. M., et al. (2020) · Cell · doi:10.1016/j.cell.2020.04.035 · Cited by 2,284 · see citing works

Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19

Zhang, Y., Xiao, M., Zhang, S., Xia, P., Cao, W., Jiang, W., Chen, H., Ding, X., Zhao, H., Zhang, H., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2007575 · Cited by 2,179 · see citing works

The immunopathology of sepsis and potential therapeutic targets

van der Poll, T., van de Veerdonk, F. L., Scicluna, B. P., & Netea, M. G. (2017) · Nature Reviews Immunology · doi:10.1038/nri.2017.36 · Cited by 1,957 · see citing works

Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo

von Brühl, M.-L., Stark, K., Steinhart, A., Chandraratne, S., Konrad, I., Lorenz, M., Khandoga, A. G., Tirniceriu, A., Coletti, R., Köllnberger, M., et al. (2012) · The Journal of Experimental Medicine · doi:10.1084/jem.20112322 · Cited by 1,827 · see citing works

Resolving the fibrotic niche of human liver cirrhosis at single-cell level

Ramachandran, P., Dobie, R., Wilson-Kanamori, J. R., Dora, E. F., Henderson, B. E. P., Luu, N. T., Portman, J. R., Matchett, K. P., Brice, M., Marwick, J. A., et al. (2019) · Nature · doi:10.1038/s41586-019-1631-3 · Cited by 1,784 · see citing works

COVID-19 illness in native and immunosuppressed states: A clinical–therapeutic staging proposal

Siddiqi, H. K., & Mehra, M. R. (2020) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2020.03.012 · Cited by 1,701 · see citing works

Monocyte emigration from bone marrow during bacterial infection requires signals mediated by chemokine receptor CCR2

Serbina, N. V., & Pamer, E. G. (2006) · Nature Immunology · doi:10.1038/ni1309 · Cited by 1,658 · see citing works

CD147-spike protein is a novel route for SARS-CoV-2 infection to host cells

Wang, K., Chen, W., Zhang, Z., Deng, Y., Lian, J., Du, P. F., Wei, D., Yang, Z., Sun, X., Gong, L., et al. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00426-x · Cited by 1,592 · see citing works

Mechanisms of action of hydroxychloroquine and chloroquine:implications for rheumatology

Schrezenmeier, E., & Dörner, T. (2020) · Nature Reviews Rheumatology · doi:10.1038/s41584-020-0372-x · Cited by 1,468 · see citing works

Dysregulated Type I Interferon and Inflammatory Monocyte-Macrophage Responses Cause Lethal Pneumonia in SARS-CoV-Infected Mice

Channappanavar, R., Fehr, A. R., Vijay, R., Mack, M., Zhao, J., Meyerholz, D. K., & Perlman, S. M. (2016) · Cell Host & Microbe · doi:10.1016/j.chom.2016.01.007 · Cited by 1,400 · see citing works

Multiple organ infection and the pathogenesis of SARS

Gu, J., Gong, E., Zhang, B., Zheng, J., Gao, Z., Zhong, Y., Zou, W., Zhan, J., Wang, S., Xie, Z., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050828 · Cited by 1,379 · see citing works

Identification of Oxidative Stress and Toll-like Receptor 4 Signaling as a Key Pathway of Acute Lung Injury

Imai, Y., Kuba, K., Neely, G. G., Yaghubian-Malhami, R., Perkmann, T., van Loo, G., Ermolaeva, M., Veldhuizen, R., Leung, Y. H. C., Wang, H., et al. (2008) · Cell · doi:10.1016/j.cell.2008.02.043 · Cited by 1,356 · see citing works

Pathogenic T-cells and inflammatory monocytes incite inflammatory storms in severe COVID-19 patients

Zhou, Y., Fu, B., Zheng, X., Wang, D., Zhao, C., Qi, Y., Sun, R., Tian, Z., Xu, X., & Wei, H. (2020) · National Science Review · doi:10.1093/nsr/nwaa041 · Cited by 1,295 · see citing works

The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS-CoV-2

Chen, L., Li, X., Chen, M., Feng, Y., & Xiong, C. (2020) · Cardiovascular Research · doi:10.1093/cvr/cvaa078 · Cited by 1,163 · see citing works

Human kidney is a target for novel severe acute respiratory syndrome coronavirus 2 infection

Diao, B., Wang, C., Wang, R., Feng, Z., Zhang, J., Yang, H., Tan, Y., Wang, H., Wang, C., Liu, L., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-22781-1 · Cited by 903 · see citing works

Plasma IP-10 and MCP-3 levels are highly associated with disease severity and predict the progression of COVID-19

Yang, Y., Shen, C., Li, J., Yuan, J., Wei, J., Huang, F., Wang, F., Li, G., Li, Y., Xing, L., et al. (2020) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2020.04.027 · Cited by 872 · see citing works

Anti-spike IgG causes severe acute lung injury by skewing macrophage responses during acute SARS-CoV infection

Liu, L., Wei, Q., Lin, Q., Fang, J., Wang, H., Kwok, H., Tang, H., Nishiura, K., Peng, J., Tan, Z., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.123158 · Cited by 830 · see citing works

The Science Underlying COVID-19

Liu, P. P., Blet, A., Smyth, D. R., & Li, H. (2020) · Circulation · doi:10.1161/circulationaha.120.047549 · Cited by 803 · see citing works

Host-directed therapy of tuberculosis based on interleukin-1 and type I interferon crosstalk

Mayer-Barber, K. D., Andrade, B. B., Oland, S. D., Amaral, E. P., Barber, D. L., Gonzales, J., Derrick, S. C., Shi, R., Kumar, N. P., Wei, W., et al. (2014) · Nature · doi:10.1038/nature13489 · Cited by 770 · see citing works

The clinical pathology of severe acute respiratory syndrome (SARS): a report from China

Ding, Y., Wang, H., Shen, H., Li, Z., Geng, J., Han, H.-X., Cai, J., Li, X., Kang, W., Weng, D., et al. (2003) · The Journal of Pathology · doi:10.1002/path.1440 · Cited by 765 · see citing works

Immune cell profiling of COVID-19 patients in the recovery stage by single-cell sequencing

Wen, W., Su, W., Tang, H., Le, W., Zhang, X., Zheng, Y., Liu, X., Xie, L., Li, J., Ye, J., et al. (2020) · Cell Discovery · doi:10.1038/s41421-020-0168-9 · Cited by 730 · see citing works

SARS-CoV-2 invades host cells via a novel route: CD147-spike proteinPreprint

Wang, K., Chen, W., Zhou, Y., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.03.14.988345 · Cited by 698 · see citing works

Severe Acute Respiratory Syndrome Coronavirus Viroporin 3a Activates the NLRP3 Inflammasome

Chen, I.-Y., Moriyama, M., Chang, M., & Ichinohe, T. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.00050 · Cited by 548 · see citing works

Trials of anti-tumour necrosis factor therapy for COVID-19 are urgently needed

Feldmann, M., Maini, R. N., Woody, J. N., Holgate, S. T., Winter, G., Rowland, M. J., Richards, D. B., & Hussell, T. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30858-8 · Cited by 531 · see citing works

Bone Marrow Mesenchymal Stem and Progenitor Cells Induce Monocyte Emigration in Response to Circulating Toll-like Receptor Ligands

Shi, C., Jia, T., Méndez‐Ferrer, S., Hohl, T. M., Serbina, N. V., Lipuma, L., Leiner, I. M., Li, M. O., Frenette, P. S., & Pamer, E. G. (2011) · Immunity · doi:10.1016/j.immuni.2011.02.016 · Cited by 508 · see citing works

Human Kidney is a Target for Novel Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) InfectionPreprint

Diao, B., Wang, C., Wang, R., et al. (2020) · medRxiv · doi:10.1101/2020.03.04.20031120 · Cited by 489 · see citing works

Correlation analysis between disease severity and inflammation-related parameters in patients with COVID-19: a retrospective study

Gong, J., Dong, H., Xia, Q., Huang, Z., Dingkun, W., Zhao, Y., Liu, W., Tu, S., Zhang, M., Wang, Q., et al. (2020) · BMC Infectious Diseases · doi:10.1186/s12879-020-05681-5 · Cited by 437 · see citing works

Ten Strategies of Interferon Evasion by Viruses

García‐Sastre, A. (2017) · Cell Host & Microbe · doi:10.1016/j.chom.2017.07.012 · Cited by 429 · see citing works

The role of oxidized phospholipids in atherosclerosis

Berliner, J. A., Leitinger, N., & Tsimikas, S. (2008) · Journal of Lipid Research · doi:10.1194/jlr.r800074-jlr200 · Cited by 404 · see citing works

SARS-Coronavirus Open Reading Frame-8b triggers intracellular stress pathways and activates NLRP3 inflammasomes

Shi, C.-S., Nabar, N. R., Huang, N., & Kehrl, J. H. (2019) · Cell Death Discovery · doi:10.1038/s41420-019-0181-7 · Cited by 402 · see citing works

Pathogenesis of Macrophage Activation Syndrome and Potential for Cytokine- Directed Therapies

Schulert, G. S., & Grom, A. A. (2014) · Annual Review of Medicine · doi:10.1146/annurev-med-061813-012806 · Cited by 401 · see citing works

Frontline Science: COVID-19 infection induces readily detectable morphologic and inflammation-related phenotypic changes in peripheral blood monocytes

Zhang, D., Guo, R., Lei, L., Liu, H., Wang, Y., Wang, Y., Qian, H., Dai, T., Zhang, T., Lai, Y., et al. (2020) · Journal of Leukocyte Biology · doi:10.1002/jlb.4hi0720-470r · Cited by 385 · see citing works

The Novel Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Directly Decimates Human Spleens and Lymph NodesPreprint

Feng, Z., Diao, B., Wang, R., Wang, G., Wang, C., Tan, Y., Liu, L., Wang, C., Liu, Y., Liu, Y., et al. (2020) · medRxiv · doi:10.1101/2020.03.27.20045427 · Cited by 369 · see citing works

Reduction and Functional Exhaustion of T Cells in Patients with Coronavirus Disease 2019 (COVID-19)Preprint

Diao, B., Wang, C., Tan, Y., et al. (2020) · medRxiv · doi:10.1101/2020.02.18.20024364 · Cited by 366 · see citing works

Exuberant elevation of IP-10, MCP-3 and IL-1ra during SARS-CoV-2 infection is associated with disease severity and fatal outcomePreprint

Yang, Y., Shen, C., Li, J., et al. (2020) · medRxiv · doi:10.1101/2020.03.02.20029975 · Cited by 274 · see citing works

Correlation Analysis Between Disease Severity and Inflammation-related Parameters in Patients with COVID-19 PneumoniaPreprint

Gong, J., Dong, H., Xia, Q., et al. (2020) · medRxiv · doi:10.1101/2020.02.25.20025643 · Cited by 264 · see citing works

The coagulopathy of acute sepsis

Simmons, J., & Pittet, J. (2015) · Current Opinion in Anaesthesiology · doi:10.1097/aco.0000000000000163 · Cited by 262 · see citing works

Impaired type I interferon activity and exacerbated inflammatory responses in severe Covid-19 patientsPreprint

Hadjadj, J., Yatim, N., Barnabei, L., et al. (2020) · medRxiv · doi:10.1101/2020.04.19.20068015 · Cited by 254 · see citing works

A Role for Oxidized Phospholipids in Atherosclerosis

Berliner, J. A., & Watson, A. D. (2005) · New England Journal of Medicine · doi:10.1056/nejmp058118 · Cited by 229 · see citing works

Siltuximab downregulates interleukin-8 and pentraxin 3 to improve ventilatory status and survival in severe COVID-19

Gritti, G., Raimondi, F., Bottazzi, B., Ripamonti, D., Riva, I., Landi, F., Alborghetti, L., Frigeni, M., Damiani, M., Micò, M. C., et al. (2021) · Leukemia · doi:10.1038/s41375-021-01299-x · Cited by 211 · see citing works

MyD88 Is Required for Protection from Lethal Infection with a Mouse-Adapted SARS-CoV

Sheahan, T. P., Morrison, T. E., Funkhouser, W., Uematsu, S., Akira, S., Baric, R. S., & Heise, M. T. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.1000240 · Cited by 207 · see citing works

Mechanical Ventilation–associated Lung Fibrosis in Acute Respiratory Distress Syndrome

Cabrera-Benítez, N. E., Laffey, J. G., Parotto, M., Spieth, P. M., Villar, J., Zhang, H., & Slutsky, A. S. (2014) · Anesthesiology · doi:10.1097/aln.0000000000000264 · Cited by 191 · see citing works

Advance in the Management of Sepsis-Induced Coagulopathy and Disseminated Intravascular Coagulation

Iba, T., Levy, J. H., Raj, A., & Warkentin, T. E. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8050728 · Cited by 180 · see citing works

The landscape of lung bronchoalveolar immune cells in COVID-19 revealed by single-cell RNA sequencingPreprint

Liao, M., Liu, Y., Yuan, J., et al. (2020) · medRxiv · doi:10.1101/2020.02.23.20026690 · Cited by 178 · see citing works

Monocyte tissue factor–dependent activation of coagulation in hypercholesterolemic mice and monkeys is inhibited by simvastatin

Owens, A. P., Passam, F. H., Antoniak, S., Marshall, S., McDaniel, A. L., Rudel, L. L., Williams, J., Hubbard, B. K., Dutton, J., Wang, J., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci58969 · Cited by 171 · see citing works

IL-6 signalling pathway inactivation with siltuximab in patients with COVID-19 respiratory failure: an observational cohort studyPreprint

Gritti, G., Raimondi, F., Ripamonti, D., et al. (2020) · medRxiv · doi:10.1101/2020.04.01.20048561 · Cited by 171 · see citing works

Type III interferons: Balancing tissue tolerance and resistance to pathogen invasion

Broggi, A., Granucci, F., & Zanoni, I. (2019) · The Journal of Experimental Medicine · doi:10.1084/jem.20190295 · Cited by 151 · see citing works

COVID-19 infection induces readily detectable morphological and inflammation-related phenotypic changes in peripheral blood monocytes, the severity of which correlate with patient outcomePreprint

Zhang, D., Guo, R., Lei, L., et al. (2020) · medRxiv · doi:10.1101/2020.03.24.20042655 · Cited by 147 · see citing works

Critical role of phospholipase A2 group IID in age-related susceptibility to severe acute respiratory syndrome–CoV infection

Vijay, R., Hua, X., Meyerholz, D. K., Miki, Y., Yamamoto, K., Gelb, M. H., Murakami, M., & Perlman, S. M. (2015) · The Journal of Experimental Medicine · doi:10.1084/jem.20150632 · Cited by 139 · see citing works

Immune Cell Profiling of COVID-19 Patients in the Recovery Stage by Single-Cell SequencingPreprint

Wen, W., Su, W., Tang, H., et al. (2020) · medRxiv · doi:10.1101/2020.03.23.20039362 · Cited by 113 · see citing works

Severe Acute Respiratory Syndrome and Venous Thromboembolism in Multiple Organs

Yi, X., Wang, L., Aibin, L., Zhu, G., Ri-quan, L., Xu-you, Z., Wei-wei, R., & Ye-nan, W. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.182.3.436 · Cited by 86 · see citing works

SARS-CoV-2 Receptor ACE2 is an Interferon-Stimulated Gene in Human Airway Epithelial Cells and Is Enriched in Specific Cell Subsets Across TissuesPreprint

Ziegler, C. G. K., Allon, S. J., Nyquist, S. K., Mbano, I., Miao, V. N., Cao, Y., Yousif, A. S., Bals, J., Hauser, B. M., Feldman, J. E., et al. (2020) · SSRN Electronic Journal · doi:10.2139/ssrn.3555145 · Cited by 75 · see citing works

Overly Exuberant Innate Immune Response to SARS-CoV-2 InfectionPreprint

Zhou, Z. L., Ren, X., Zhang, L., Zhong, J., Xiao, Y., Jia, Z., Guo, L., Yang, J., Wang, C., Jiang, S., et al. (2020) · SSRN Electronic Journal · doi:10.2139/ssrn.3551623 · Cited by 59 · see citing works

Metabolic Modulation of Inflammation-Induced Activation of Coagulation

Levi, M. M., Nieuwdorp, M., van der Poll, T., & Stroes, E. S. G. (2008) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-2008-1066020 · Cited by 41 · see citing works

Extrapulmonary manifestations of COVID-19

Gupta, A., Madhavan, M. V., Sehgal, K., Nair, N., Mahajan, S., Sehrawat, T. S., Bikdeli, B., Ahluwalia, N., Ausiello, J. C., Wan, E. Y., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0968-3 · Cited by 3,185 · see citing works

An inflammatory cytokine signature predicts COVID-19 severity and survival

Del Valle, D. M., Kim-Schulze, S., Huang, H.-H., Beckmann, N. D., Nirenberg, S., Wang, B., Lavin, Y., Swartz, T. H., Madduri, D., Stock, A., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-1051-9 · Cited by 2,605 · see citing works

Severe COVID-19 Is Marked by a Dysregulated Myeloid Cell Compartment

Schulte-Schrepping, J., Reusch, N., Paclik, D., Baßler, K., Schlickeiser, S., Zhang, B., Krämer, B., Krammer, T., Brumhard, S., Bonaguro, L., et al. (2020) · Cell · doi:10.1016/j.cell.2020.08.001 · Cited by 1,461 · see citing works

The cytokine storm and COVID-19

Hu, B., Huang, S., & Yin, L. (2021) · Journal of Medical Virology · doi:10.1002/jmv.26232 · Cited by 1,655 · see citing works

Immunological considerations for COVID-19 vaccine strategies

Jeyanathan, M., Afkhami, S., Smaill, F., Miller, M. S., Lichty, B. D., & Xing, Z. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-020-00434-6 · Cited by 1,015 · see citing works

A dynamic COVID-19 immune signature includes associations with poor prognosis

Laing, A. G., Lorenc, A., del Molino del Barrio, I., Das, A., Fish, M., Monin, L., Muñoz-Ruiz, M., McKenzie, D. R., Hayday, T. S., Francos-Quijorna, I., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-1038-6 · Cited by 946 · see citing works

Elevated Glucose Levels Favor SARS-CoV-2 Infection and Monocyte Response through a HIF-1α/Glycolysis-Dependent Axis

Codo, A. C., Davanzo, G. G., Monteiro, L. D. B., de Souza, G. F., Muraro, S. P., Virgílio-da-Silva, J. V., Prodonoff, J. S., Carregari, V. C., de Biagi, C. A. O., Crunfli, F., et al. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.07.007 · Cited by 908 · see citing works

Immunophenotyping of COVID-19 and influenza highlights the role of type I interferons in development of severe COVID-19

Lee, J. S., Park, S.-W., Jeong, H. W., Ahn, J. Y., Choi, S. J., Lee, H., Choi, B., Nam, S. K., Sa, M., Kwon, J., et al. (2020) · Science Immunology · doi:10.1126/sciimmunol.abd1554 · Cited by 805 · see citing works

Comprehensive mapping of immune perturbations associated with severe COVID-19

Kuri-Cervantes, L., Pampena, M. B., Meng, W., Rosenfeld, A. M., Ittner, C. A. G., Weisman, A. R., Agyekum, R. S., Mathew, D., Baxter, A. E., Vella, L. A., et al. (2020) · Science Immunology · doi:10.1126/sciimmunol.abd7114 · Cited by 723 · see citing works

The hypercoagulable state in COVID-19: Incidence, pathophysiology, and management

Abou-Ismail, M. Y., Diamond, A., Kapoor, S., Arafah, Y., & Nayak, L. (2020) · Thrombosis Research · doi:10.1016/j.thromres.2020.06.029 · Cited by 694 · see citing works

COVID-19 and the human innate immune system

Schultze, J. L., & Aschenbrenner, A. C. (2021) · Cell · doi:10.1016/j.cell.2021.02.029 · Cited by 714 · see citing works

Polyunsaturated fatty acids and fatty acid-derived lipid mediators: Recent advances in the understanding of their biosynthesis, structures, and functions

Dyall, S. C., Balas, L., Bazan, N. G., Brenna, J. T., Chiang, N., Souza, F. D. C., Dalli, J., Durand, T., Galano, J., Lein, P. J., et al. (2022) · Progress in Lipid Research · doi:10.1016/j.plipres.2022.101165 · Cited by 681 · see citing works

Effects of COVID-19 on the Nervous System

Iadecola, C., Anrather, J., & Kamel, H. (2020) · Cell · doi:10.1016/j.cell.2020.08.028 · Cited by 663 · see citing works

How COVID-19 induces cytokine storm with high mortality

Hojyo, S., Uchida, M., Tanaka, K., Hasebe, R., Tanaka, Y., Murakami, M., & Hirano, T. (2020) · Inflammation and Regeneration · doi:10.1186/s41232-020-00146-3 · Cited by 663 · see citing works

FcγR-mediated SARS-CoV-2 infection of monocytes activates inflammation

Junqueira, C., Crespo, Â. C., Ranjbar, S., de Lacerda, L., Lewandrowski, M., Ingber, J., Parry, B. A., Ravid, S., Clark, S. A., Schrimpf, M. R., et al. (2022) · Nature · doi:10.1038/s41586-022-04702-4 · Cited by 669 · see citing works

The Emerging Threat of (Micro)Thrombosis in COVID-19 and Its Therapeutic Implications

McFadyen, J. D., Stevens, H., & Peter, K. (2020) · Circulation Research · doi:10.1161/circresaha.120.317447 · Cited by 592 · see citing works

Dendritic cell migration in inflammation and immunity

Liu, J., Zhang, X., Cheng, Y., & Cao, X. (2021) · Cellular and Molecular Immunology · doi:10.1038/s41423-021-00726-4 · Cited by 543 · see citing works

The COVID-19 puzzle: deciphering pathophysiology and phenotypes of a new disease entity

Osuchowski, M., Winkler, M., Skirecki, T., Cajander, S., Shankar-Hari, M., Lachmann, G., Monneret, G., Venet, F., Bauer, M., Brunkhorst, F., et al. (2021) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(21)00218-6 · Cited by 396 · see citing works

Natural killer cell immunotypes related to COVID-19 disease severity

Maucourant, C., Filipovic, I., Ponzetta, A., Aleman, S., Cornillet, M., Hertwig, L., Strunz, B., Lentini, A., Reinius, B., Brownlie, D., et al. (2020) · Science Immunology · doi:10.1126/sciimmunol.abd6832 · Cited by 476 · see citing works

Multisystem inflammatory syndrome in children related to COVID-19: a systematic review

Hoste, L., Paemel, R. V., & Haerynck, F. (2021) · European Journal of Pediatrics · doi:10.1007/s00431-021-03993-5 · Cited by 454 · see citing works

Specialized pro-resolving mediator network: an update on production and actions

Chiang, N., & Serhan, C. N. (2020) · Essays in Biochemistry · doi:10.1042/ebc20200018 · Cited by 441 · see citing works

C-reactive protein and clinical outcomes in patients with COVID-19

Smilowitz, N. R., Kunichoff, D. F., Garshick, M. S., Shah, B., Pillinger, M. H., Hochman, J. S., & Berger, J. S. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehaa1103 · Cited by 442 · see citing works

Arterial Thrombosis in Coronavirus Disease 2019 Patients: A Rapid Systematic Review

Cheruiyot, I., Kipkorir, V., Ngure, B., Misiani, M., Munguti, J., & Ogeng'o, J. (2021) · Annals of Vascular Surgery · doi:10.1016/j.avsg.2020.08.087 · Cited by 434 · see citing works

Thrombocytopathy and endotheliopathy: crucial contributors to COVID-19 thromboinflammation

Gu, S. X., Tyagi, T., Jain, K., Gu, V. W., Lee, S. H., Hwa, J. M., Kwan, J. M., Krause, D. S., Lee, A. I., Halene, S., et al. (2020) · Nature Reviews Cardiology · doi:10.1038/s41569-020-00469-1 · Cited by 414 · see citing works

RNA modifications: importance in immune cell biology and related diseases

Cui, L., Ma, R., Cai, J., Guo, C., Chen, Z., Yao, L., Wang, Y., Fan, R., Wang, X., & Shi, Y. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01175-9 · Cited by 423 · see citing works

Targeting the NLRP3 Inflammasome in Severe COVID-19

Freeman, T. L., & Swartz, T. H. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01518 · Cited by 406 · see citing works

Type III interferons disrupt the lung epithelial barrier upon viral recognition

Broggi, A., Ghosh, S., Sposito, B., Spreafico, R., Balzarini, F., Cascio, A. L., Clementi, N., Santis, M. D., Mancini, N., Granucci, F., et al. (2020) · Science · doi:10.1126/science.abc3545 · Cited by 398 · see citing works

Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions for optimal therapeutic protection

Winkler, E. S., Gilchuk, P., Yu, J., Bailey, A. L., Chen, R. E., Chong, Z., Zost, S. J., Jang, H., Huang, Y., Allen, J. D., et al. (2021) · Cell · doi:10.1016/j.cell.2021.02.026 · Cited by 366 · see citing works

Effect of tocilizumab on clinical outcomes at 15 days in patients with severe or critical coronavirus disease 2019: randomised controlled trial.

Veiga, V. C., Prats, J. A. G. G., Farias, D. L. C., Rosa, R. G., Dourado, L. K., Zampieri, F. G., Machado, F. R., Lopes, R. D., Berwanger, O., Azevedo, L. C. P., et al. (2021) · BMJ · doi:10.1136/bmj.n84 · Cited by 388 · see citing works

COVID-19 vaccines: The status and perspectives in delivery points of view

Chung, J. Y., Thone, M. N., & Kwon, Y. J. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.12.011 · Cited by 375 · see citing works

Cytokine storm and COVID-19: a chronicle of pro-inflammatory cytokines

Fara, A. F., Mitrev, Z. K., Rosalia, R. A., & Assas, M. B. (2020) · Open Biology · doi:10.1098/rsob.200160 · Cited by 368 · see citing works

Longitudinal Multi-omics Analyses Identify Responses of Megakaryocytes, Erythroid Cells, and Plasmablasts as Hallmarks of Severe COVID-19

Bernardes, J. P., Mishra, N., Tran, F., Bahmer, T., Best, L., Blase, J. I., Bordoni, D., Franzenburg, J., Geisen, U., Josephs-Spaulding, J., et al. (2020) · Immunity · doi:10.1016/j.immuni.2020.11.017 · Cited by 322 · see citing works

Covid‐19 and kidney injury: Pathophysiology and molecular mechanisms

Ahmadian, E., Khatibi, S. M. H., Soofiyani, S. R., Abediazar, S., Shoja, M. M., Ardalan, M., & Vahed, S. Z. (2020) · Reviews in Medical Virology · doi:10.1002/rmv.2176 · Cited by 366 · see citing works

SARS-CoV-2, COVID-19 and the aging immune system

Bartleson, J. M., Radenkovic, D., Covarrubias, A. J., Furman, D., Winer, D. A., & Verdin, E. (2021) · Nature Aging · doi:10.1038/s43587-021-00114-7 · Cited by 359 · see citing works

Virus-induced senescence is a driver and therapeutic target in COVID-19

Lee, S., Yu, Y., Trimpert, J., Benthani, F., Mairhofer, M., Richter-Pechanska, P., Wyler, E., Belenki, D., Kaltenbrunner, S., Pammer, M., et al. (2021) · Nature · doi:10.1038/s41586-021-03995-1 · Cited by 350 · see citing works

T cell response to SARS-CoV-2 infection in humans: A systematic review

Shrotri, M., van Schalkwyk, M. C., Post, N., Eddy, D., Huntley, C., Leeman, D., Rigby, S., Williams, S. V., Bermingham, W. H., Kellam, P., et al. (2021) · PLoS ONE · doi:10.1371/journal.pone.0245532 · Cited by 349 · see citing works

Cellular Nanosponges Inhibit SARS-CoV-2 Infectivity

Zhang, Q., Honko, A. N., Zhou, J., Gong, H., Downs, S. N., Vasquez, J. H., Fang, R. H., Gao, W., Griffiths, A., & Zhang, L. (2020) · Nano Letters · doi:10.1021/acs.nanolett.0c02278 · Cited by 346 · see citing works

Discriminating mild from critical COVID-19 by innate and adaptive immune single-cell profiling of bronchoalveolar lavages

Wauters, E., Mol, P. V., Garg, A. D., Jansen, S., Herck, Y. V., Vanderbeke, L., Bassez, A., Boeckx, B., Malengier‐Devlies, B., Timmerman, A., et al. (2021) · Cell Research · doi:10.1038/s41422-020-00455-9 · Cited by 339 · see citing works

COVID-19, immunothrombosis and venous thromboembolism: biological mechanisms

Loo, J., Spittle, D. A., & Newnham, M. (2021) · Thorax · doi:10.1136/thoraxjnl-2020-216243 · Cited by 337 · see citing works

An immune-based biomarker signature is associated with mortality in COVID-19 patients

Abers, M. S., Delmonte, O. M., Ricotta, E., Fintzi, J., Fink, D. L., de Jesus, A. A., Zarember, K. A., Alehashemi, S., Oikonomou, V., Desai, J. V., et al. (2020) · JCI Insight · doi:10.1172/jci.insight.144455 · Cited by 335 · see citing works

Next-Generation Sequencing of T and B Cell Receptor Repertoires from COVID-19 Patients Showed Signatures Associated with Severity of Disease

Schultheiß, C., Paschold, L., Simnica, D., Mohme, M., Willscher, E., von Wenserski, L., Scholz, R., Wieters, I., Dahlke, C., Tolosa, E., et al. (2020) · Immunity · doi:10.1016/j.immuni.2020.06.024 · Cited by 334 · see citing works

Contribution of monocytes and macrophages to the local tissue inflammation and cytokine storm in COVID-19: Lessons from SARS and MERS, and potential therapeutic interventions

Jafarzadeh, A., Chauhan, P. S., Saha, B., Jafarzadeh, S., & Nemati, M. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118102 · Cited by 327 · see citing works

The pro-inflammatory cytokines in COVID-19 pathogenesis: What goes wrong?

Darif, D., Hammi, I., Kihel, A., Saik, I. E. I., Guessous, F., & Akarid, K. (2021) · Microbial Pathogenesis · doi:10.1016/j.micpath.2021.104799 · Cited by 327 · see citing works

Inflammasome activation at the crux of severe COVID-19

Vora, S. M., Lieberman, J., & Wu, H. (2021) · Nature reviews. Immunology · doi:10.1038/s41577-021-00588-x · Cited by 323 · see citing works

Coronavirus disease 2019 (COVID‐19): An overview of the immunopathology, serological diagnosis and management

Anka, A. U., Tahir, M. I., Abubakar, S. D., Alsabbagh, M. Y., Zian, Z., Hamedifar, H., Sabzevari, A., & Azizi, G. (2020) · Scandinavian Journal of Immunology · doi:10.1111/sji.12998 · Cited by 348 · see citing works

A neutrophil activation signature predicts critical illness and mortality in COVID-19

Meizlish, M. L., Pine, A. B., Bishai, J. D., Goshua, G., Nadelmann, E. R., Simonov, M., Chang, C., Zhang, H., Shallow, M., Bahel, P., et al. (2021) · Blood Advances · doi:10.1182/bloodadvances.2020003568 · Cited by 318 · see citing works

Macrophage Polarity and Disease Control

Kadomoto, S., Izumi, K., & Mizokami, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms23010144 · Cited by 319 · see citing works

Systemic and organ-specific immune-related manifestations of COVID-19

Ramos‐Casals, M., Brito‐Zerón, P., & Xavier Mariette, A. (2021) · Nature Reviews Rheumatology · doi:10.1038/s41584-021-00608-z · Cited by 307 · see citing works

Cohort study to evaluate the effect of vitamin D, magnesium, and vitamin B12 in combination on progression to severe outcomes in older patients with coronavirus (COVID-19)

Tan, C. W., Ho, L. P., Kalimuddin, S., Cherng, B. P. Z., Teh, Y. E., Thien, S. Y., Wong, H. M., Tern, P. J. W., Chandran, M., Chay, J. W. M., et al. (2020) · Nutrition · doi:10.1016/j.nut.2020.111017 · Cited by 305 · see citing works

Clinical criteria for COVID-19-associated hyperinflammatory syndrome: a cohort study

Webb, B. J., Peltan, I. D., Jensen, P., Hoda, D., Hunter, B. D., Silver, A. E., Starr, N. J., Buckel, W. R., Grisel, N., Hummel, E., et al. (2020) · The Lancet Rheumatology · doi:10.1016/s2665-9913(20)30343-x · Cited by 292 · see citing works

A human circulating immune cell landscape in aging and COVID-19

Zheng, Y., Liu, X., Le, W., Xie, L., Li, H., Wen, W., Wang, S., Ma, S., Huang, Z., Ye, J., et al. (2020) · Protein & Cell · doi:10.1007/s13238-020-00762-2 · Cited by 270 · see citing works

Pharmaco-Immunomodulatory Therapy in COVID-19

Rizk, J. G., Kalantar‐Zadeh, K., Mehra, M. R., Lavie, C. J., Rizk, Y., & Forthal, D. N. (2020) · Drugs · doi:10.1007/s40265-020-01367-z · Cited by 289 · see citing works

Baricitinib restrains the immune dysregulation in patients with severe COVID-19

Bronte, V., Ugel, S., Tinazzi, E., Vella, A., De Sanctis, F., Canè, S., Batani, V., Trovato, R., Fiore, A., Petrova, V., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci141772 · Cited by 281 · see citing works

In situ detection of SARS-CoV-2 in lungs and airways of patients with COVID-19

Schaefer, I., Padera, R. F., Solomon, I. H., Kanjilal, S., Hammer, M. M., Hornick, J. L., & Sholl, L. M. (2020) · Modern Pathology · doi:10.1038/s41379-020-0595-z · Cited by 278 · see citing works

Disease severity-specific neutrophil signatures in blood transcriptomes stratify COVID-19 patients

(DeCOI), G. C.-1. O. I., Aschenbrenner, A. C., Mouktaroudi, M., Krämer, B., Oestreich, M., Antonakos, N., Nuesch-Germano, M., Gkizeli, K., Bonaguro, L., Reusch, N., et al. (2021) · Genome Medicine · doi:10.1186/s13073-020-00823-5 · Cited by 255 · see citing works

High titers and low fucosylation of early human anti–SARS-CoV-2 IgG promote inflammation by alveolar macrophages

Hoepel, W., Chen, H., Geyer, C. E., Allahverdiyeva, S., Manz, X. D., de Taeye, S. W., Aman, J., Mes, L., Steenhuis, M., Griffith, G. R., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abf8654 · Cited by 276 · see citing works

COVID-19 and Oxidative Stress

Chernyak, B. V., Popova, E. N., Prikhodko, A. S., Grebenchikov, O. A., Zinovkina, L. A., & Zinovkin, R. A. (2020) · Biochemistry (Moscow) · doi:10.1134/s0006297920120068 · Cited by 283 · see citing works

Two distinct immunopathological profiles in autopsy lungs of COVID-19

Nienhold, R., Ciani, Y., Koelzer, V. H., Tzankov, A., Haslbauer, J. D., Menter, T., Schwab, N., Henkel, M., Frank, A., Zsikla, V., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-18854-2 · Cited by 246 · see citing works

SARS-CoV-2 engages inflammasome and pyroptosis in human primary monocytes

Ferreira, A. C., Soares, V. C., de Azevedo-Quintanilha, I. G., Dias, S. D. S. G., Rodrigues, N. F., Sacramento, C. Q., Mattos, M., de Freitas, C. S., Temerozo, J. R., Teixeira, L., et al. (2021) · Cell Death Discovery · doi:10.1038/s41420-021-00428-w · Cited by 269 · see citing works

Mucosal immune responses to infection and vaccination in the respiratory tract

Mettelman, R. C., Allen, E. K., & Thomas, P. G. (2022) · Immunity · doi:10.1016/j.immuni.2022.04.013 · Cited by 272 · see citing works

Evidence Regarding Vitamin D and Risk of COVID-19 and Its Severity

Mercola, J. M., Grant, W. B., & Wagner, C. L. (2020) · Nutrients · doi:10.3390/nu12113361 · Cited by 268 · see citing works

Gut microbiota in COVID-19: key microbial changes, potential mechanisms and clinical applications

Zhang, F., Lau, R. I., Liu, Q., Su, Q., Chan, F. K. L., & Ng, S. C. (2022) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-022-00698-4 · Cited by 275 · see citing works

Monocytes and Macrophages in COVID-19

Knoll, R., Schultze, J. L., & Schulte-Schrepping, J. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.720109 · Cited by 269 · see citing works

The role of IL-6 and other mediators in the cytokine storm associated with SARS-CoV-2 infection

Copaescu, A. M., Smibert, O. C., Gibson, A., Phillips, E. J., & Trubiano, J. A. (2020) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2020.07.001 · Cited by 258 · see citing works

SARS-CoV-2 spike protein S1 subunit induces pro-inflammatory responses via toll-like receptor 4 signaling in murine and human macrophages

Shirato, K., & Kizaki, T. (2021) · Heliyon · doi:10.1016/j.heliyon.2021.e06187 · Cited by 263 · see citing works

Prospects for a safe COVID-19 vaccine

Haynes, B. F., Corey, L., Fernandes, P., Gilbert, P. B., Hotez, P. J., Rao, S., Santos, M. R., Schuitemaker, H., Watson, M., & Arvin, A. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.abe0948 · Cited by 261 · see citing works

Decoy nanoparticles protect against COVID-19 by concurrently adsorbing viruses and inflammatory cytokines

Rao, L., Xia, S., Xu, W., Tian, R., Yu, G., Gu, C., Pan, P., Meng, Q.-F., Cai, X., Qu, D., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2014352117 · Cited by 261 · see citing works

Pathophysiology of COVID-19: Mechanisms Underlying Disease Severity and Progression

Bohn, M. K., Hall, A., Sepiashvili, L., Jung, B., Steele, S., & Adeli, K. (2020) · Physiology · doi:10.1152/physiol.00019.2020 · Cited by 259 · see citing works

An updated and comprehensive review of the antiviral potential of essential oils and their chemical constituents with special focus on their mechanism of action against various influenza and coronaviruses

Wani, A. R., Yadav, K., Khursheed, A., & Rather, M. A. (2020) · Microbial Pathogenesis · doi:10.1016/j.micpath.2020.104620 · Cited by 264 · see citing works

The role of iron in the pathogenesis of COVID-19 and possible treatment with lactoferrin and other iron chelators

Habib, H. M., Ibrahim, S., Zaim, A., & Ibrahim, W. H. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111228 · Cited by 253 · see citing works

Untimely TGFβ responses in COVID-19 limit antiviral functions of NK cells

Witkowski, M., Tizian, C., Ferreira‐Gomes, M., Niemeyer, D., Jones, T. C., Heinrich, F., Frischbutter, S., Angermair, S., Hohnstein, T., Mattiola, I., et al. (2021) · Nature · doi:10.1038/s41586-021-04142-6 · Cited by 247 · see citing works

Chemokines and chemokine receptors during COVID-19 infection

Khalil, B. A., Elemam, N. M., & Maghazachi, A. A. (2021) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2021.01.034 · Cited by 246 · see citing works

Monocyte-driven atypical cytokine storm and aberrant neutrophil activation as key mediators of COVID-19 disease severity

Vanderbeke, L., Van Mol, P., Van Herck, Y., De Smet, F., Humblet-Baron, S., Martinod, K., Antoranz, A., Arijs, I., Boeckx, B., Bosisio, F. M., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-24360-w · Cited by 247 · see citing works

SARS-CoV-2 Vertical Transmission with Adverse Effects on the Newborn Revealed Through Integrated Immunohistochemical, Electron Microscopy and Molecular Analyses of Placenta

Facchetti, F., Bugatti, M., Drera, E., Tripodo, C., Sartori, E., Cancila, V., Papaccio, M., Castellani, R., Casola, S. S., Boniotti, M. B., et al. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2020.102951 · Cited by 247 · see citing works

The Multifaceted Role of Glutathione S-Transferases in Health and Disease

Mazari, A. M. A., Zhang, L., Ye, Z., Zhang, J., Tew, K. D., & Townsend, D. M. (2023) · Biomolecules · doi:10.3390/biom13040688 · Cited by 247 · see citing works

Longitudinal immune profiling reveals key myeloid signatures associated with COVID-19

Mann, E. R., Menon, M., Knight, S., Konkel, J. E., Jagger, C. P., Shaw, T. N., Krishnan, S., Rattray, M., Ustianowski, A., Bakerly, N. D., et al. (2020) · Science Immunology · doi:10.1126/sciimmunol.abd6197 · Cited by 242 · see citing works

Lymphocyte Subset Counts in COVID ‐19 Patients: A Meta‐Analysis

Huang, W., Bérubé, J., McNamara, M., Saksena, S., Hartman, M., Arshad, T., Bornheimer, S. J., & O’Gorman, M. R. G. (2020) · Cytometry Part A · doi:10.1002/cyto.a.24172 · Cited by 237 · see citing works

GM-CSF-based treatments in COVID-19: reconciling opposing therapeutic approaches

Lang, F. M., Lee, M.-C., Teijaro, J. R., Becher, B., & Hamilton, J. A. (2020) · Nature reviews. Immunology · doi:10.1038/s41577-020-0357-7 · Cited by 232 · see citing works

The differential immune responses to COVID-19 in peripheral and lung revealed by single-cell RNA sequencing

Xu, G., Qi, F., Li, H., Yang, Q., Wang, H., Wang, X., Liu, X., Zhao, J., Liao, X., Liu, Y., et al. (2020) · Cell Discovery · doi:10.1038/s41421-020-00225-2 · Cited by 228 · see citing works

COVID-19 and therapy with essential oils having antiviral, anti-inflammatory, and immunomodulatory properties

Asif, M., Saleem, M., Saadullah, M., Yaseen, H. S., & Zarzour, R. A. (2020) · Inflammopharmacology · doi:10.1007/s10787-020-00744-0 · Cited by 233 · see citing works

Systemic IL-15, IFN-γ, and IP-10/CXCL10 signature associated with effective immune response to SARS-CoV-2 in BNT162b2 mRNA vaccine recipients

Bergamaschi, C., Terpos, E., Rosati, M., Angel, M., Bear, J., Stellas, D., Karaliota, S., Apostolakou, F., Bagratuni, T., Patseas, D., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109504 · Cited by 233 · see citing works

Vascular Disease and Thrombosis in SARS-CoV-2-Infected Rhesus Macaques

Aid, M., Busman-Sahay, K., Vidal, S. J., Maliga, Z., Bondoc, S., Starke, C., Terry, M., Jacobson, C. A., Wrijil, L., Ducat, S., et al. (2020) · Cell · doi:10.1016/j.cell.2020.10.005 · Cited by 215 · see citing works

Venous thromboembolism in patients with COVID-19: Systematic review and meta-analysis

Porfidia, A., Valeriani, E., Pola, R., Porreca, E., Rutjes, A. W., & Nisio, M. D. (2020) · Thrombosis Research · doi:10.1016/j.thromres.2020.08.020 · Cited by 231 · see citing works

Maternal-fetal immune responses in pregnant women infected with SARS-CoV-2

Garcia‐Flores, V., Romero, R. J., Xu, Y., Theis, K. R., Arenas‐Hernandez, M., Miller, D., Peyvandipour, A., Bhatti, G., Galaz, J., Gershater, M., et al. (2022) · Nature Communications · doi:10.1038/s41467-021-27745-z · Cited by 233 · see citing works

SARS-CoV-2 spike protein promotes IL-6 trans-signaling by activation of angiotensin II receptor signaling in epithelial cells

Patra, T., Meyer, K., Geerling, L., Isbell, T. S., Hoft, D. F., Brien, J. D., Pinto, A. K., Ray, R. B., & Ray, R. (2020) · PLoS Pathogens · doi:10.1371/journal.ppat.1009128 · Cited by 221 · see citing works

Devilishly radical NETwork in COVID-19: Oxidative stress, neutrophil extracellular traps (NETs), and T cell suppression

Schönrich, G., Raftery, M. J., & Samstag, Y. (2020) · Advances in Biological Regulation · doi:10.1016/j.jbior.2020.100741 · Cited by 221 · see citing works

Machine learning approaches in COVID-19 diagnosis, mortality, and severity risk prediction: A review

Alballa, N., & Al-Turaiki, I. M. (2021) · Informatics in Medicine Unlocked · doi:10.1016/j.imu.2021.100564 · Cited by 226 · see citing works

Natural history of COVID-19 and current knowledge on treatment therapeutic options

dos Santos, W. G. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110493 · Cited by 222 · see citing works

Multi-omic profiling reveals widespread dysregulation of innate immunity and hematopoiesis in COVID-19

Wilk, A. J., Lee, M. J., Wei, B., Parks, B. E., Pi, R., Martínez-Colón, G. J., Ranganath, T., Zhao, N. Q., Taylor, S., Becker, W. R., et al. (2021) · The Journal of Experimental Medicine · doi:10.1084/jem.20210582 · Cited by 208 · see citing works

Outcome of SARS-CoV-2 infection is linked to MAIT cell activation and cytotoxicity

Flament, H., Rouland, M., Beaudoin, L., Toubal, A., Bertrand, L., Lebourgeois, S., Rousseau, C., Soulard, P., Gouda, Z., Cagninacci, L., et al. (2021) · Nature Immunology · doi:10.1038/s41590-021-00870-z · Cited by 214 · see citing works

Diversity of Macrophages in Lung Homeostasis and Diseases

Hou, F., Xiao, K., Tang, L., & Xie, L. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.753940 · Cited by 216 · see citing works

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): a Systemic Infection

Synowiec, A., Szczepański, A., Barreto-Durán, E., Lie, L. K., & Pyrć, K. (2021) · Clinical Microbiology Reviews · doi:10.1128/cmr.00133-20 · Cited by 221 · see citing works

Clinical applications of human organoids

Verstegen, M. M. A., Coppes, R. P., Béghin, A., Coppi, P. D., Gerli, M., de Graeff, N., Pan, Q., Saito, Y., Shi, S., ZADPOOR, A. A., et al. (2025) · Nature Medicine · doi:10.1038/s41591-024-03489-3 · Cited by 228 · see citing works

Aging immunity may exacerbate COVID-19

Akbar, A. N., & Gilroy, D. W. (2020) · Science · doi:10.1126/science.abb0762 · Cited by 209 · see citing works

The immune response to SARS-CoV-2 and COVID-19 immunopathology – Current perspectives

Boechat, J. L., Chora, I., Morais, A., & Delgado, L. (2021) · Pulmonology · doi:10.1016/j.pulmoe.2021.03.008 · Cited by 214 · see citing works

COVID-19 as part of the hyperferritinemic syndromes: the role of iron depletion therapy

Perricone, C., Bartoloni, E., Bursi, R., Cafaro, G., Guidelli, G. M., Shoenfeld, Y., & Gerli, R. (2020) · Immunologic Research · doi:10.1007/s12026-020-09145-5 · Cited by 238 · see citing works

Cutting Edge: Severe SARS-CoV-2 Infection in Humans Is Defined by a Shift in the Serum Lipidome, Resulting in Dysregulation of Eicosanoid Immune Mediators

Schwarz, B. H., Sharma, L., Roberts, L. M., Peng, X., Bermejo, S. D., Leighton, I. A., Casanovas‐Massana, A., Minasyan, M., Farhadian, S., Ko, A. I., et al. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.2001025 · Cited by 205 · see citing works

Overview: Systemic Inflammatory Response Derived From Lung Injury Caused by SARS-CoV-2 Infection Explains Severe Outcomes in COVID-19

Polidoro, R. B., Hagan, R. S., Santiago, R. R. D. S., & Schmidt, N. W. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01626 · Cited by 202 · see citing works

Platelets contribute to disease severity in COVID‐19

Barrett, T. J., Bilaloglu, S., Cornwell, M., Burgess, H. M., Virginio, V. W., Drenkova, K., Ibrahim, H., Yuriditsky, E., Aphinyanaphongs, Y., Lifshitz, M. S., et al. (2021) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.15534 · Cited by 203 · see citing works

Deep insight into cytokine storm: from pathogenesis to treatment

Nie, J., Zhou, L., Tian, W., Liu, X., Yang, L., Yang, X., Zhang, Y., Wei, S., Wang, D. W., & Wei, J. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02178-y · Cited by 224 · see citing works

Monocytes and macrophages in COVID-19: Friends and foes

Meidaninikjeh, S., Sabouni, N., Marzouni, H. Z., Bengar, S., Khalili, A., & Jafari, R. (2021) · Life Sciences · doi:10.1016/j.lfs.2020.119010 · Cited by 151 · see citing works

Targeting Mononuclear Phagocytes to Treat COVID-19

Pence, B. D., & Cory, T. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.98967

Immunopathology of Hyperinflammation in COVID-19

Gustine, J. N., & Jones, D. (2021) · The American Journal of Pathology · doi:10.1016/j.ajpath.2020.08.009 · Cited by 516 · see citing works

Monocytes and Macrophages in COVID-19

Knoll, R., Schultze, J. L., & Schulte-Schrepping, J. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.720109 · Cited by 269 · see citing works

Effective treatment of SARS-CoV-2-infected rhesus macaques by attenuating inflammation

Lu, S., Zhao, J., Dong, J., Liu, H., Zhu, Y., Li, H., Liu, L., Yang, Y., Sun, S., Song, Y., et al. (2020) · Cell Research · doi:10.1038/s41422-020-00414-4 · Cited by 14 · see citing works